Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Tanda Biotechnology Co., Ltd. is a prominent biotechnology enterprise headquartered in the Wuhan East Lake High-tech Development Zone (Biolake), China. The company is a specialist in industrial microbiology and is widely recognized for its leadership in the research, development, and large-scale production of biological pesticides, particularly those based on Bacillus thuringiensis (Bt). In addition to its agricultural portfolio, Wuhan Tanda Biotechnology serves the broader life sciences community by manufacturing and distributing research reagents, including ELISA kits, recombinant proteins, and polyclonal/monoclonal antibodies. The company operates advanced microbial fermentation and protein purification facilities, supporting both its commercial product lines and its diagnostic reagent business. As a key player in the Wuhan biotech cluster, it focuses on sustainable agricultural solutions and providing essential tools for biomedical research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Tanda Biotechnology.